Targeting mucosal immunity in the battle to develop a mastitis vaccine

Journal of Mammary Gland Biology and Neoplasia

Volumn 16, Issue 4, 2011, Pages 409-419

  Bharathan, Mini ^a   Mullarky, Isis K ^b  

^a INTREXON CORPORATION   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Antigen presentation; Bovine; Dendritic cell; Mastitis; Staphylococcus aureus; Vaccine

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD14 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ARTICLE; ASPERGILLUS FUMIGATUS; CELLULAR IMMUNITY; DENDRITIC CELL; FEMALE; HUMAN; IMMUNOLOGICAL MEMORY; MASTITIS; MEDICAL RESEARCH; MEMORY CELL; MUCOSAL IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TH17 CELL; VACCINATION;

ANIMALS; CATTLE; FEMALE; HUMANS; IMMUNITY, MUCOSAL; MASTITIS; VACCINATION;

EID: 84855647207     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-011-9233-1     Document Type: Article

References (115)

1. Medzhitov R, Janeway Jr C. Innate immunity. N Engl J Med. 2000;343(5):338-44. doi:10.1056/NEJM200008033430506. (Pubitemid 30616701)
2. Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197-216. doi:10.1146/annurev. immunol.20.083001.084359. (Pubitemid 34293424)
3. Corradin C, Lanzavecchia A. Chemical and functional analysis of MHC class II-restricted T cell epitopes. Int Rev Immunol. 1991;7(2):139-47.
4. Andersen MH, Schrama D. Thor Straten P. Becker JC Cytotoxic T cells J Invest Dermatol. 2006;126(1):32-41. doi:10.1038/sj. jid.5700001.
5. Goodnow CC, Vinuesa CG, Randall KL, Mackay F, Brink R. Control systems and decision making for antibody production. Nat Immunol. 2010;11(8):681-8. doi:10.1038/ni.1900.
6. Johanns TM, Ertelt JM, Rowe JH, Way SS. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog. 2010;6(8):e1001043. doi:10.1371/journal. ppat.1001043.
7. Mertens J, Fabri M, Zingarelli A, Kubacki T, Meemboor S, Groneck L. Streptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking. PLoS Pathog. 2009;5(9):e1000596. doi:10.1371/journal.ppat.1000596.
8. Sundquist M, Quiding-Jarbrink M. Helicobacter pylori and its effect on innate and adaptive immunity: New insights and vaccination strategies. Expert Rev Gastroenterol Hepatol. 2010;4(6):733-44. doi:10.1586/egh.10.71.
9. Urdahl KB, Shafiani S, Ernst JD. Initiation and regulation of Tcell responses in tuberculosis. Mucosal Immunol. 2011;4 (3):288-93. doi:10.1038/mi.2011.10.
10. Sordillo LM, Shafer-Weaver K, DeRosa D. Immunobiology of the mammary gland. J Dairy Sci. 1997;80(8):1851-65. doi:10.3168/jds.S0022-0302(97)76121-6. (Pubitemid 127446909)
11. Cho JS, Pietras EM, Garcia NC, Ramos RI, Farzam DM, Monroe HR et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. The Journal of Clinical Investigation. 2010;0(0):0-.
12. Chung DR, Kasper DL, Panzo RJ, Chitnis T, Grusby MJ, Sayegh MH, et al. CD4+ T cells mediate abscess formation in intraabdominal sepsis by an IL-17-dependent mechanism. J Immunol. 2003;170(4):1958-63. (Pubitemid 36197415)
13. Lin L, Ibrahim AS, Xu X, Farber JM, Avanesian V, Baquir B. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 2009;5(12):e1000703. doi:10.1371/journal. ppat.1000703.
14. Beekhuizen H, van de Gevel JS. Gamma Interferon Confers Resistance to Infection with Staphylococcus aureus in HumanVascular Endothelial Cells by Cooperative Proinflammatory and Enhanced Intrinsic Antibacterial Activities. Infect Immun. 2007;75(12):5615-26. (Pubitemid 350207798)
15. Pepper M, Jenkins MK. Origins of CD4(+) effector and central memory T cells. Nat Immunol. 2011;12(6):467-71.
16. Fox LK, Gay JM. Contagious mastitis. Vet Clin North Am Food Anim Pract. 1993;9(3):475-87.
17. Smith KL, Hogan JS. Environmental mastitis. Vet Clin North Am Food Anim Pract. 1993;9(3):489-98.
18. Gonzalez RN, Cullor JS, Jasper DE, Farver TB, Bushnell RB, Oliver MN. Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine. Can J Vet Res. 1989;53(3):301-5.
19. Hogan JS, Smith KL, Todhunter DA, Schoenberger PS. Field trial to determine efficacy of an Escherichia coli J5 mastitis vaccine. J Dairy Sci. 1992;75(1):78-84. doi:10.3168/jds. S0022-0302(92)77741-8.
20. Tomita GM, Todhunter DA, Hogan JS, Smith KL. Immunization of dairy cows with an Escherichia coli J5 lipopolysaccharide vaccine. J Dairy Sci. 1995;78(10):2178-85. doi:10.3168/jds. S0022-0302(95)76845-X.
21. Projan SJ, Nesin M, Dunman PM. Staphylococcal vaccines and immunotherapy: To dream the impossible dream? Curr Opin Pharmacol. 2006;6(5):473-9. doi:10.1016/j.coph.2006.04.005. (Pubitemid 44362069)
22. Schaffer AC, Lee JC. Vaccination and passive immunisation against Staphylococcus aureus. Int J Antimicrob Agents. 2008;32 SUPPL. 1:S71-8. doi:10.1016/j.ijantimicag.2008.06.009.
23. Nordhaug ML, Nesse LL, Norcross NL, Gudding R. A field trial with an experimental vaccine against Staphylococcus aureus mastitis in cattle. 2. Antibody response. J Dairy Sci. 1994;77(5):1276-84.
24. Nordhaug ML, Nesse LL, Norcross NL, Gudding R. A field trial with an experimental vaccine against Staphylococcus aureus mastitis in cattle. 1. Clinical parameters. J Dairy Sci. 1994;77 (5):1267-75.
25. Iwatsuki K, Yamasaki O, Morizane S, Oono T. Staphylococcal cutaneous infections: Invasion, evasion and aggression. J Dermatol Sci. 2006;42(3):203-14.
26. Mamo W, Boden M, Flock JI. Vaccination with Staphylococcus aureus fibrinogen binding proteins (FgBPs) reduces colonisation of S. aureus in a mouse mastitis model. FEMS Immunol Med Microbiol. 1994;10(1):47-53. (Pubitemid 24355530)
27. Mamo W, Jonsson P, Flock JI, Lindberg M, Muller HP, Wadstrom T, et al. Vaccination against Staphylococcus aureus mastitis: Immunological response of mice vaccinated with fibronectin-binding protein (FnBP-A) to challenge with S. aureus. Vaccine. 1994;12(11):988-92.
28. Simonetti O, Cirioni O, Ghiselli R, Goteri G, Scalise A, Orlando F, et al. RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2008;52(6):2205-11. doi:10.1128/ AAC.01340-07. (Pubitemid 351758560)
29. Leitner G, Lubashevsky E, Trainin Z. Staphylococcus aureus vaccine against mastitis in dairy cows, composition and evaluation of its immunogenicity in a mouse model. Vet Immunol Immunopathol. 2003;93(3-4):159-67. (Pubitemid 38367442)
30. Leitner G, Yadlin N, Lubashevsy E, Ezra E, Glickman A, Chaffer M, et al. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II Field trial Vet Immunol Immunopathol. 2003;93(3-4):153-8. (Pubitemid 38367441)
31. Dryla A, Prustomersky S, Gelbmann D, Hanner M, Bettinger E, Kocsis B, et al. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin Diagn Lab Immunol. 2005;12(3):387-98. doi:10.1128/CDLI.12.3.387-398.2005. (Pubitemid 41175334)
32. Middleton JR. Staphylococcus aureus antigens and challenges in vaccine development. Expert Rev Vaccines. 2008;7(6):805-15. doi:10.1586/14760584.7.6. 805.
33. Prado ME, Almeida RA, Ozen C, Luther DA, Lewis MJ, Headrick SJ. Vaccination of dairy cows with recombinant Streptococcus uberis adhesion molecule induces antibodies that reduce adherence to and internalization of S. uberis into bovine mammary epithelial cells. Vet Immunol Immunopathol. 2011;141(3-4):201-8. doi:10.1016/j.vetimm.2011.02.023.
34. Denis M, Lacy-Hulbert SJ, Buddle BM, Williamson JH, Wedlock DN. Streptococcus uberis-specific T cells are present in mammary gland secretions of cows and can be activated to kill S. uberis. Vet Res Commun. 2011;35(3):145-56. doi:10.1007/s11259-011-9462-1.
35. Yang XM, Li N, Chen JM, Ou YZ, Jin H, Lu HJ, et al. Comparative proteomic analysis between the invasive and commensal strains of Staphylococcus epidermidis. FEMS Microbiol Lett. 2006;261(1):32-40. (Pubitemid 43999697)
36. Kniemeyer O, Lessing F, Brakhage AA. Proteome analysis for pathogenicity and new diagnostic markers for Aspergillus fumigatus. Med Mycol. 2008:1-7.
37. Muthukrishnan G, Quinn GA, Lamers RP, Diaz C, Cole AL, Chen S, et al. Exoproteome of Staphylococcus aureus reveals putative determinants of nasal carriage. J Proteome Res. 2011;10 (4):2064-78. doi:10.1021/pr200029r.
38. Broker BM, van Belkum A. Immune proteomics of Staphylococcus aureus. Proteomics. 2011;11(15):3221-31. doi:10.1002/ pmic.201100010.
39. Dreisbach A, Hempel K, Buist G, Hecker M, Becher D, van Dijl JM. Profiling the surfacome of Staphylococcus aureus. Proteomics. 2010;10(17):3082-96. doi:10.1002/pmic.201000062.
40. Burvenich C, Bannerman DD, Lippolis JD, Peelman L, Nonnecke BJ, Kehrli Jr ME, et al. Cumulative physiological events influence the inflammatory response of the bovine udder to Escherichia coli infections during the transition period. J Dairy Sci. 2007;90 SUPPL. 1:E39-54. doi:10.3168/ jds.2006-696.
41. Boehmer JL, Ward JL, Peters RR, Shefcheck KJ, McFarland MA, Bannerman DD. Proteomic analysis of the temporal expression of bovine milk proteins during coliform mastitis and label-free relative quantification. J Dairy Sci. 2010;93(2):593-603. doi:10.3168/jds.2009-2526.
42. Boehmer JL, Bannerman DD, Shefcheck K, Ward JL. Proteomic analysis of differentially expressed proteins in bovine milk during experimentally induced Escherichia coli mastitis. J Dairy Sci. 2008;91(11):4206-18. doi:10.3168/ jds.2008-1297.
43. Wolf C, Kusch H, Monecke S, Albrecht D, Holtfreter S, von Eiff C, et al. Genomic and proteomic characterization of Staphylococcus aureus mastitis isolates of bovine origin. Proteomics. 2011;11(12):2491-502. doi:10.1002/pmic.201000698.
44. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med. 1973;137 (5):1142-62.
45. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245-52. doi:10.1038/32588. (Pubitemid 28155090)
46. Ueno H, Klechevsky E, Morita R, Aspord C, Cao T, Matsui T, et al. Dendritic cell subsets in health and disease. Immunol Rev. 2007;219:118-42. (Pubitemid 47393528)
47. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002;2(3):151-61. doi:10.1038/nri746. (Pubitemid 37336516)
48. McLachlan JB, Catron DM, Moon JJ, Jenkins MK. Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity. 2009;30 (2):277-88. doi:10.1016/j.immuni. 2008.11.013.
49. Romani N, Holzmann S, Tripp CH, Koch F, Stoitzner P. Langerhans cells-dendritic cells of the epidermis. APMIS. 2003;111(7-8):725-40.
50. Shortman K, Naik SH. Steady-state and inflammatory dendriticcell development. Nat Rev Immunol. 2007;7(1):19-30. doi:10.1038/nri1996. (Pubitemid 46020824)
51. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811. doi:10.1146/annurev.immunol.18.1.767. (Pubitemid 30365397)
52. Trumpfheller C, Finke JS, Lopez CB, Moran TM, Moltedo B, Soares H, et al. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J Exp Med. 2006;203(3):607-17. doi:10.1084/jem.20052005.
53. Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H, et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med. 2004;199(6):815-24. doi:10.1084/jem.20032220. (Pubitemid 38375201)
54. Boscardin SB, Hafalla JC, Masilamani RF, Kamphorst AO, Zebroski HA, Rai U, et al. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J Exp Med. 2006;203(3):599-606. doi:10.1084/jem. 20051639.
55. Bozzacco L, Trumpfheller C, Siegal FP, Mehandru S, Markowitz M, Carrington M, et al. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci U S A 2007;104(4):1289-94. doi:10.1073/pnas.0610383104. (Pubitemid 46183997)
56. Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature. 1995;375(6527):151-5. doi:10.1038/375151a0.
57. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, et al. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol. 2000;151(3):673-84.
58. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med. 2002;196(12):1627-38. (Pubitemid 36026474)
59. Hawiger D, Inaba K, Dorsett Y, Guo M,Mahnke K, Rivera M, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194(6):769-79. (Pubitemid 32983013)
60. Sallusto F. The role of chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses. Haematologica. 1999;84(4):28-31.
61. Weninger W, von Andrian UH. Chemokine regulation of naive T cell traffic in health and disease. Semin Immunol. 2003;15 (5):257-70. doi:10.1016/j.smim. 2003.08.007. (Pubitemid 38156054)
62. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J, et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity. 2004;21 (2):279-88. doi:10.1016/j.immuni.2004.06.014. (Pubitemid 39094056)
63. Bromley SK, Thomas SY, Luster AD. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol. 2005;6(9):895-901. doi:10.1038/ni1240. (Pubitemid 43090444)
64. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271-96. doi:10.1146/annurev.iy.09.040191.001415.
65. Austyn JM. New insights into the mobilization and phagocytic activity of dendritic cells. J Exp Med. 1996;183(4):1287-92. (Pubitemid 26134270)
66. Ferwerda G, Kramer M, de Jong D, Piccini A, Joosten LA, Devesaginer I, et al. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL- 1beta. Eur J Immunol. 2008;38(1):184-91. doi:10.1002/ eji.200737103.
67. Willment JA, Brown GD. C-type lectin receptors in antifungal immunity. Trends Microbiol. 2008;16(1):27-32. doi:10.1016/j. tim.2007.10.012.
68. Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H. Immature, but not inactive: The tolerogenic function of immature dendritic cells. Immunol Cell Biol. 2002;80(5):477-83. doi:10.1046/j.1440-1711.2002.01115.x.
69. Lanzavecchia A, Sallusto F. The instructive role of dendritic cells on T cell responses: Lineages, plasticity and kinetics. Curr Opin Immunol. 2001;13(3):291-8. (Pubitemid 32537700)
70. Mellman I, Steinman RM. Dendritic cells: Specialized and regulated antigen processing machines. Cell. 2001;106 (3):255-8. (Pubitemid 32772607)
71. Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, Julkunen I, et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol. 1999;29(5):1617-25. doi:10.1002/(SICI)1521- 4141(199905) 29:053.0.CO;2-3. (Pubitemid 29224467)
72. Harrison CJ. Innate immunity as a key element in host defense against methicillin resistant Staphylo-coccus aureus. Minerva Pediatr. 2009;61(5):503-14.
73. Chomarat P, Dantin C, Bennett L, Banchereau J, Palucka AK. TNF skews monocyte differentiation from macrophages to dendritic cells. J Immunol. 2003;171(5):2262-9. (Pubitemid 37028309)
74. Hiasa M, Abe M, Nakano A, Oda A, Amou H, Kido S, et al. GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE). Blood. 2009;114(20):4517-26. doi:10.1182/blood-2009-04-215020.
75. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997;385 (6618):729-33. doi:10.1038/385729a0. (Pubitemid 27098094)
76. Moss ML, Jin SL, Becherer JD, Bickett DM, Burkhart W, Chen WJ, et al. Structural features and biochemical properties of TNFalpha converting enzyme (TACE). J Neuroimmunol. 1997;72 (2):127-9. (Pubitemid 27062767)
77. Colotta F, Borre A, Wang JM, Tattanelli M, Maddalena F, Polentarutti N, et al. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol. 1992;148(3):760-5.
78. Serbina NV, Jia T, Hohl TM, Pamer EG.Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol. 2008;26:421-52. doi:10.1146/annurev. immunol.26.021607.090326. (Pubitemid 351600381)
79. Fogg DK, Sibon C, Miled C, Jung S, Aucouturier P, Littman DR, et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science. 2006;311(5757):83-7. doi:10.1126/science.1117729. (Pubitemid 43063063)
80. Serbina NV, Pamer EG. Coordinating innate immune cells to optimize microbial killing. Immunity. 2008;29(5):672-4. doi:10.1016/j.immuni.2008.10.003.
81. Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, de Saint-Vis B, Jacquet C, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med. 1996;184(2):695-706. (Pubitemid 26324123)
82. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179(4):1109-18.
83. Denis M, Buddle BM. Bovine dendritic cells are more permissive for Mycobacterium bovis replication than macrophages, but release more IL-12 and induce better immune T-cell proliferation. Immunol Cell Biol. 2008;86(2):185-91. doi:10.1038/sj.icb.7100124. (Pubitemid 351301756)
84. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science. 1990;248(4961):1349-56.
85. Carter LL, Carreno BM. Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation. Immunol Res. 2003;28(1):49-59. doi:10.1385/ IR:28:1:49. (Pubitemid 37088542)
86. Carreno BM, Bennett F, Chau TA, Ling V, Luxenberg D, Jussif J, et al. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol. 2000;165(3):1352-6. (Pubitemid 30604565)
87. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol. 2005;23:515-48. doi:10.1146/ annurev.immunol.23.021704.115611. (Pubitemid 40563179)
88. Henrickson SE, Mempel TR, Mazo IB, Liu B, Artyomov MN, Zheng H, et al. T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nat Immunol. 2008;9(3):282-91. doi:10.1038/ni1559. (Pubitemid 351267325)
89. McHeyzer-Williams LJ, McHeyzer-WilliamsMG.Antigen-specific memory B cell development. Annu Rev Immunol. 2005;23:487-513. doi:10.1146/annurev.immunol.23. 021704.115732. (Pubitemid 40563178)
90. Salmon H. The mammary gland and neonate mucosal immunity. Vet Immunol Immunopathol. 1999;72(1-2):143-55.
91. Brandtzaeg P. Mucosal immunity: Induction, dissemination, and effector functions. Scand J Immunol. 2009;70(6):505-15. doi:10.1111/j.1365-3083.2009. 02319.x.
92. Liu JZ, Pezeshki M, Raffatellu M. Th17 cytokines and hostpathogen interactions at the mucosa: Dichotomies of help and harm. Cytokine. 2009;48(1-2):156-60. doi:10.1016/j. cyto.2009.07.005.
93. Gomez MI, Sordelli DO, Buzzola FR, Garcia VE. Induction of cell-mediated immunity to Staphylococcus aureus in the mouse mammary gland by local immunization with a live attenuated mutant. Infect Immun. 2002;70(8):4254-60. (Pubitemid 34790934)
94. Vordermeier HM, Villarreal-Ramos B, Cockle PJ, McAulay M, Rhodes SG, Thacker T, et al. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect Immun. 2009;77(8):3364-73. doi:10.1128/ IAI.00287-09.
95. McLoughlin RM, Solinga RM, Rich J, Zaleski KJ, Cocchiaro JL, Risley A, et al. CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc Natl Acad Sci U S A 2006;103(27):10408-13. doi:10.1073/ pnas.0508961103. (Pubitemid 44051180)
96. Islander U, Andersson A, Lindberg E, Adlerberth I, Wold AE, Rudin A. Superantigenic Staphylococcus aureus Stimulates Production of Interleukin-17 from Memory but Not Naive T Cells. Infect Immun. 2010;78(1):381-6. doi:10.1128/iai.00724-09.
97. Roark CL, Simonian PL, Fontenot AP, Born WK, O'Brien RL. gammadelta T cells: An important source of IL-17. Curr Opin Immunol. 2008;20(3):353-7. doi:10.1016/j.coi.2008.03.006.
98. Hogg AE, Worth A, Beverley P, Howard CJ, Villarreal-Ramos B. The antigen-specific memory CD8+ T-cell response induced by BCG in cattle resides in the CD8+gamma/deltaTCR-CD45RO+ T-cell population. Vaccine. 2009;27(2):270-9. doi:10.1016/j. vaccine.2008.10.053.
99. Totte P, Duperray C, Dedieu L. CD62L defines a subset of pathogen-specific bovine CD4 with central memory cell characteristics. Dev Comp Immunol. 2010;34(2):177-82. doi:10.1016/ j.dci.2009.09.005.
100. Masopust D, Ha SJ, Vezys V, Ahmed R. Stimulation history dictates memory CD8 T cell phenotype: Implications for primeboost vaccination. J Immunol. 2006;177(2):831-9. (Pubitemid 44036583)
101. Fraser JD, Proft T. The bacterial superantigen and superantigenlike proteins. Immunol Rev. 2008;225(1):226-43.
102. Seo KS, Lee SU, Park YH, Davis WC, Fox LK, Bohach GA. Long-term staphylococcal enterotoxin C1 exposure induces soluble factor-mediated immunosuppression by bovine CD4+ and CD8+ T cells. Infect Immun. 2007;75(1):260-9. doi:10.1128/IAI.01358-06. (Pubitemid 46047901)
103. Park YH, Lee SU, Ferens WA, Samuels S, Davis WC, Fox LK, et al. Unique features of bovine lymphocytes exposed to a staphylococcal enterotoxin. J Vet Sci. 2006;7(3):233-9. (Pubitemid 44387071)
104. Brosnahan AJ, Schlievert PM. Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome. FEBS J. 2011. doi:10.1111/j.1742-4658.2011.08151.x.
105. Seo KS, Park JY, Davis WC, Fox LK, McGuire MA, Park YH. Superantigen-mediated differentiation of bovine monocytes into dendritic cells. J Leukoc Biol. 2009. doi:10.1189/ jlb.0608338.
106. Yuan L, Lowell GH, Hoover DL, Colleton CA, Hammack Sr CA, Young LD, et al. Kinetics of cellular and cytokine responses in a chimeric mouse model for the study of staphylococcal enterotoxin B pathogenesis. Immunol Lett. 2000;71(1):19-26. (Pubitemid 30068607)
107. Zecconi A, Cesaris L, Liandris E, Dapra V, Piccinini R. Role of several Staphylococcus aureus virulence factors on the inflammatory response in bovine mammary gland. Microb Pathog. 2006;40(4):177-83. doi:10.1016/j.micpath.2006.01. 001.
108. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990;248(4956):705-11.
109. Ferens WA, Bohach GA. Persistence of Staphylococcus aureus on mucosal membranes: Superantigens and internalization by host cells. J Lab Clin Med. 2000;135(3):225-30. doi:10.1067/ mlc.2000.105179. (Pubitemid 30132344)
110. Scholl PR, Geha RS. MHC class II signaling in B-cell activation. Immunol Today. 1994;15(9):418-22. (Pubitemid 24272186)
111. Castagliuolo I, Piccinini R, Beggiao E, Palu G, Mengoli C, Ditadi F, et al. Mucosal genetic immunization against four adhesins protects against Staphylococcus aureus-induced mastitis in mice. Vaccine. 2006;24(20):4393-402. doi:10.1016/j. vaccine.2006.02.055. (Pubitemid 44376362)
112. Klonowski KD, Williams KJ, Marzo AL, Blair DA, Lingenheld EG, Lefrancois L. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity. 2004;20(5):551-62. (Pubitemid 38638125)
113. Woodland DL, Kohlmeier JE. Migration, maintenance and recall of memory T cells in peripheral tissues. Nat Rev Immunol. 2009;9(3):153-61. doi:10.1038/nri2496.
114. Brandtzaeg P. The mucosal immune system and its integration with the mammary glands. J Pediatr. 2010;156(2 SUPPL.):S8-15. doi:10.1016/j.jpeds.2009. 11.014.
115. Bourry A, Poutrel B. Bovine mastitis caused by Listeria monocytogenes: Kinetics of antibody responses in serum and milk after experimental infection. J Dairy Sci. 1996;79 (12):2189-95. doi:10.3168/jds.S0022-0302(96)76595-5. (Pubitemid 126429019)